Vorm Ziekte Thema Locatie

Follistatin-like 1 is crucial for normal postnatal development of the pulmonary vasculature

  • Tania, Navessa P. MSc
  • Department of Molecular Pharmacology University of Groningen
  • 23 augustus 2016
  • (
  • afgerond project

Keyword: COPD comorbidity Follistatin-like 1 pulmonary vasculature

ATS 2015: Novel therapeutics and targets for pulmonary disease

  • Poppinga, Wilfred J.
  • Rijksuniversiteit Groningen
  • 1 oktober 2015
  • (
  • afgerond project

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease mainly caused by cigarette smoking. Current pharmacotherapy is aimed at relieving a distinct subset of COPD symptoms, however the anti-inflammatory drugs are less successful. During the 201 5 American Thoracic Society (ATS) annual meeting there were new combinations of existing drugs presented, and also new potential...

Keyword: ATS 2015 COPD

Developmental and pathologic roles of Follistatin-like 1 in the lung

  • Tania, N.P.
  • University of Groningen , Department of Molecular Pharmacology
  • 23 september 2015
  • (
  • afgerond project

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that is characterized by airway remodeling, persistent inflammation, and emphysema (1). Patients with COPD suffer from airflow obstruction that is not fully reversible. Extracellular matrix remodeling of the airways and lung tissue is a hallmark of morphological changes in patients with COPD. Excessive production of the ...

Keyword: COPD follistatin like-1 (Fstl1)

Atherosclerosis Development

  • Khedoe, P.P.S.
  • Leids Universitair Medisch Centrum
  • 6 november 2012
  • afgerond project

Atherosclerosis Development In APOE*3-LEIDEN Mice Is Not Affected By Elastase-Induced Emphysema

Keyword: ATS 2012 Atherosclerosis

Congres Pharmacolog: New targets and treatment strategies in COPD

  • Oldenburger, A.
  • Rijksuniversiteit Groningen
  • 5 november 2012
  • afgerond project


Keyword: COPD

Gratis nieuwsbrief

Blijf op de hoogte van het laatste nieuws over subsidies, zorg en onderzoek naar astma, COPD en andere longziekten.